目的研究胸腔积液端粒酶活性及CYFRA21-1在良、恶性胸腔积液中的诊断价值。方法用聚合酶链反应—酶联免疫吸附分析法(PCR-ELISA)检测胸腔积液端粒酶活性,用免疫放射分析法(IRA)测定胸液CYFRA21-1水平,并与细胞学诊断结果进行比较,根据最终的诊断结果,67例患者分成2组:(1)非恶性胸腔积液35例;(2)恶性胸腔积液32例。结果非恶性胸腔积液中端粒酶阳性2例(5.7%),恶性胸腔积液阳性26例(81.3%),端粒酶活性测定诊断恶性胸腔积液的灵敏度为81.3%,特异度94%,正确率93 ...
魏仲航, 杨杰, 魏延君
doaj
Aim To evaluate the clinical value of serum high mobility group box chromosomal protein 1 (HMGB1) levels in making the early diagnosis of recurrent cervical squamous cell carcinomas (CSCC) and compare it with the value of serum squamous cell ...
Ma, Zhifang +17 more
core
The value of combined detection of CEA, CYFRA21-1, SCC-Ag, and pro-GRP in the differential diagnosis of lung cancer. [PDF]
Li J, Chen Y, Wang X, Wang C, Xiao M.
europepmc +1 more source
Analysis of influencing factors of serum SCCA elevation in 309 CAP patients with normal CEA,NSE and CYFRA21-1. [PDF]
Wang J, Tang X, Liu X, Zhang J.
europepmc +1 more source
CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis. [PDF]
Li B +10 more
europepmc +1 more source
Prognostic significance of pre-treatment serum Cyfra21-1 as a tumor marker in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy. [PDF]
Li L +9 more
europepmc +1 more source
Clinical Significance of CYFRA21-1 as a Screening Test of Lung Cancer
openaire +2 more sources
An Investigation of the Availability of CYFRA21-1 as a Tumor Marker in Head and Neck Cancer.
Hideyuki KAWAUCHI +4 more
openaire +2 more sources
High-Sensitivity Detection of the Lung Cancer Biomarker CYFRA21-1 in Serum Samples Using a Carboxyl-MoS2 Functional Film for SPR-Based Immunosensors. [PDF]
Chiu NF, Yang HT.
europepmc +1 more source

